Public market insider buying at The Valens Company (VLNS)

Public market insider buying at The Valens Company (T:VLNS)

Andrew Tyler Robson, CEO and Director, acquired 59,000 Common Shares on a direct ownership basis at prices ranging from $1.900 to $1.970 on October 18th, 2021. This represents a $114,300 investment into the company's shares and an account share holdings change of 1.9%.

The Valens Company is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

The Valens Company Inc. is a Canada-based manufacturer of cannabis derivative products. The Company provides cannabis processing services across five core technologies, in addition to product development, formulation and manufacturing of cannabis consumer packaged goods. The Company's products are formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on product development and innovation. Its patented emulsification technology, SoRSE, converts cannabis oil into water-soluble emulsions for integration into a variety of product formats. The Company's subsidiary Valens Labs operates a cannabis testing lab and provides analytical services. The Company's subsidiary, Southern Cliff Brands Inc., manufactures hard cider in the manufacturing facility in Greater Toronto Area.